Skip to main content
VulnerabilityPublished

CVE-2026-56245: Cap-go capgo · Improper Privilege Management

Affects Cap-go capgoSource CVE Database V5

0
Compare

Not known to be exploited · CVSS 8.8 High : upgrade to 12.128.2 soon.

Data as of 5 Nov 2026, 00:01 UTC

CVSS 4.0 base score
8.8High
How severe the flaw is on the 0–10 CVSS scale.
EPSS
0.3% chance of exploitation in 30 days – higher than 27% of CVEsExploit Prediction Scoring System: the likelihood attackers will use this flaw soon.
Patch
Available – fixed in 12.128.2
CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:N/VC:N/VI:H/VA:L/SC:N/SI:N/SA:N

Exploitation evidence

  1. Disclosed: evidence found.

    CVE published 24 Jun 2026

  2. Detectable: no evidence on record.

    No public nuclei template indexed

  3. Weaponized: no evidence on record.

    No public exploit code indexed in Metasploit or Exploit-DB

  4. Exploited in the wild: no evidence on record.

    Not in CISA KEV and no source reports exploitation

  5. Observed by OffSeq Mirage: no evidence on record.

    No attack traffic recorded by OffSeq Mirage sensors

A missing step is not evidence of safety. Sources: cve.org (opens in a new tab), the Metasploit, Exploit-DB and nuclei-templates index as of 5 Nov 2026.

What to do

Upgrade Cap-go capgo to 12.128.2.

Affected software

ProductAffectedFixed in
Cap-gocapgoAffected
  • <12.128.2
Fixed in
  • 12.128.2

AI-suggested

If you cannot patch yet, restrict access to the affected RPC endpoint if possible and monitor for unusual activity related to billing and quota data manipulation.

Description

Supabase Capgo before 12.128.2 contains an authorization bypass vulnerability in the SECURITY DEFINER record_build_time RPC function that allows unauthenticated attackers to insert arbitrary build-time records. Attackers can exploit this by calling POST /rest/v1/rpc/record_build_time with a public API key to poison billing and quota data for any organization, enabling resource exhaustion and cross-tenant billing manipulation.

References

Community reviews

Loading reviews…